Healthy adults
Conditions
Interventions
Daily ingestion of two sugar-coated MSHF001 pills twice a day, after breakfast meals and at bed time for 4 weeks. After about 4 weeks washout period, daily ingestion of two sugar-coated placebo pills
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: -Healthy female -Subjects whose Kupperman Kohnenki Shohgai Index, KKSI, is more than medium degree, or below medium on a case by case basis. -Subjects who have the symptoms of hot flushes.
Exclusion criteria
Exclusion criteria: -Subjects with systemic illness -Subjects who regularly take medicine. -Subjects who are outpatients or were treated by doctor within a month. -Subjects who are under Hormone Replacement Therapy, HRT, and/or medication which would affect blood hormone levels. -Subjects who are pregnant or lactating, or planned to become pregnant in the near future. -Subjects with smoking habit. -Subjects with drinking habit in 4 or more days a week. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects who easily have skin rashes. -Subjects with potential conflict of interest. -Subjects who plan to participate in other clinical trials during this study. -Subjects who are judged to be inappropriate for this study by the investigator for other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the 4 weeks ingestion of the development code MSHF001 on general malaise and so on. | — |
Countries
Japan
Contacts
Public ContactMayumi Ohtsuka
Kao Corporation Biological Science Research
Outcome results
None listed